ACET Market Cap History
Below is a table of the ACET market cap history going back to 1/30/2018:

Date ACET Market Cap
1/30/2018484.20M
5/1/2018297.41M
9/13/2018397.16M
10/15/2018347.43M
11/5/2018363.65M
2/12/2019248.57M
9/16/2020301.68M
11/3/2020210.90M
3/10/2021472.10M
5/12/2021419.62M

Also see: ACET Shares Outstanding History
and ACET YTD Return
ACET Historical Market Cap:
-4.27% CAGR
ACET Historical Market Cap: +-4.27% CAGR

Mouse over chart for data details
1/30/20185/1/20189/13/201810/15/201811/5/20182/12/20199/16/202011/3/20203/10/20215/12/2021
Adicet Bio is a clinical-stage biopharmaceutical company developing medicines that target the biology of aging to prevent or treat age-related diseases with the potential to extend healthy lifespan. Co.'s main program selectively inhibits the target of rapamycin complex 1 (TORC1), a conserved pathway that contributes to the age-related decline in function of multiple organ systems. Co.'s product candidate, RTB101, is an oral and selective inhibitor of TORC1. RTB101 inhibits the phosphorylation of multiple targets downstream of TORC1. Co. has licensed the rights to its TORC1 program, including RTB101 alone or in combination with everolimus, from Novartis International Pharmaceutical Ltd. We show 10 historical shares outstanding datapoints in our ACET shares outstanding history coverage, used to compute ACET market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ACET market cap history over the course of time is important for investors interested in comparing ACET's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ACET versus a peer is one thing; comparing ACET market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ACET can fluctuate over the course of history. With this page we aim to empower investors researching ACET by allowing them to research the ACET market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ACET:
ACET SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aceto (ACET) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ACHC Market Cap History
ACHN Market Cap History
ACHV Market Cap History
ACOR Market Cap History
ACRS Market Cap History
ACRX Market Cap History
ACST Market Cap History
ADMA Market Cap History
ADMP Market Cap History
ADMS Market Cap History
More Healthcare companies »

 

ACET Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.